New antibiotics for selective treatment of gastrointestinal infection caused by Clostridium difficile

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.10, 2010-10, pp. : 1389-1399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention and treatment of Clostridium difficile infection

By Gouliouris Theodore Brown Nicholas M Aliyu Sani H

Clinical Medicine, Vol. 11, Iss. 1, 2011-02 ,pp. : 75-79

Royal College Of Physicians

Access to resources Recommend Favorite

Clostridium difficile infection

By Clark Tristan Wiselka Martin

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 544-547

Royal College Of Physicians

Access to resources Recommend Favorite

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection

By Miller Mark

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1569-1578

Informa Healthcare

Access to resources Recommend Favorite

Novel avenues for Clostridium difficile infection drug discovery

By Zucca Mario Scutera Sara Savoia Dianella

Expert Opinion on Drug Discovery, Vol. 8, Iss. 4, 2013-04 ,pp. : 459-477

Informa Healthcare

Access to resources Recommend Favorite

Therapy of Clostridium difficile infection: perspectives on a changing paradigm

By Tran Mai-Chi N Claros Marina C Goldstein Ellie J C

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2375-2386

Informa Healthcare

Access to resources Recommend Favorite